Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Jennifer W. Leiding, Danielle E. Arnold, Suhag Parikh, Brent Logan, Rebecca A. Marsh, Linda M. Griffith, Ruizhe Wu, Sharon Kidd, Kanwaldeep Mallhi, Deepak Chellapandian, Stephanie J. Si Lim, Eyal Grunebaum, E. Liana Falcone, Luis Murguia-Favela, Debbi Grossman, Vinod K. Prasad, Jennifer R. Heimall, Fabien Touzot, Lauri M. Burroughs, Jack Bleesing, Neena Kapoor, Jasmeen Dara, Olatundun Williams, Malika Kapadia, Benjamin R. Oshrine, Jeffrey J. Bednarski, Ahmad Rayes, Hey Chong, Geoffrey D. E. Cuvelier, Lisa R. Forbes Satter, Caridad Martinez, Mark T. Vander Lugt, Lolie C. Yu, Shanmuganathan Chandrakasan, Avni Joshi, Susan E. Prockop, Blachy J. Dávila Saldaña, Victor Aquino, Larisa A. Broglie, Christen L. Ebens, Lisa M. Madden, Kenneth DeSantes, Jordan Milner, Hemalatha G. Rangarajan, Ami J. Shah, Alfred P. Gillio, Alan P. Knutsen, Holly K. Miller, Theodore B. Moore, Pamela Graham, Andrea Bauchat, Nancy J. Bunin, Pierre Teira, Aleksandra Petrovic, Sharat Chandra, Hisham Abdel-Azim, Morna J. Dorsey, Olga Birbrayer, Morton J. Cowan, Christopher C. Dvorak, Elie Haddad, Donald B. Kohn, Luigi D. Notarangelo, Sung-Yun Pai, Jennifer M. Puck, Michael A. Pulsipher, Troy R. Torgerson, Harry L. Malech, Elizabeth M. Kang

Blood (2023) 142 (24): 2105–2118.

https://doi.org/10.1182/blood.2022019586

Published: 2023

Includes: Supplemental data

Journal Articles

Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection

Michael Grimley, Gabriela Maron, Carlos A Gomez, Vinod K. Prasad, Jasmeen Dara, Genovefa A Papanicolaou, Koji Fukushima, Robert F. Wynn, Michael Boeckh

Blood (2023) 142 (Supplement 1): 112.

https://doi.org/10.1182/blood-2023-179901

Published: 2023

Journal Articles

Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study

Blood (2015) 125 (13): 2164–2172.

https://doi.org/10.1182/blood-2014-11-608075

Published: 2015

Includes: Supplemental data

Journal Articles

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

Blood (2013) 122 (22): 3651–3658.

https://doi.org/10.1182/blood-2013-05-501510

Published: 2013

Includes: Supplemental data

Journal Articles

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning

Blood (2013) 121 (19): 3981–3987.

https://doi.org/10.1182/blood-2012-09-455238

Published: 2013

Journal Articles

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Blood (2012) 120 (21): 467.

https://doi.org/10.1182/blood.V120.21.467.467

Published: 2012

Journal Articles

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Priti Tewari, MD, Susan Wood, PNP, Paul L Martin, MD, PhD, Suhag H Parikh, MD, Paul Szabolcs, MD, Kristin M Page, MD, Timothy Driscoll, MD, Joanne Kurtzberg, MD, Vinod K. Prasad, MBBS, MD, MRCP,

Blood (2009) 114 (22): 3398.

https://doi.org/10.1182/blood.V114.22.3398.3398

Published: 2009

Journal Articles

Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies.

Vinod K. Prasad, MBBS, MD, MRCP, Dong-Feng Chen, PhD, Gloria Broadwater, Nancy L Reinsmoen, Adella Clark, BS, Nelson J Chao, MD, MBA, David A. Rizzieri, MD

Blood (2008) 112 (11): 3255.

https://doi.org/10.1182/blood.V112.11.3255.3255

Published: 2008

Journal Articles

Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients.

Vinod K. Prasad, MBBS, MD, MRCP, Premjit Gill, MBChB, Richard Vinesett, BS, Suhag H Parikh, MD, Paul Szabolcs, MD, Timothy A Driscoll, MD, Kristin M Page, MD, Susan Wood, PNP, Deborah Semmel, FNP, Paul L Martin, MD, PhD, Joanne Kurtzberg, MD

Blood (2008) 112 (11): 1975.

https://doi.org/10.1182/blood.V112.11.1975.1975

Published: 2008

Journal Articles

Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies

Joanne Kurtzberg, Vinod K. Prasad, Shelly L. Carter, John E. Wagner, Lee Ann Baxter-Lowe, Donna Wall, Neena Kapoor, Eva C. Guinan, Stephen A. Feig, Elizabeth L. Wagner, Nancy A. Kernan

Blood (2008) 112 (10): 4318–4327.

https://doi.org/10.1182/blood-2007-06-098020

Published: 2008

Journal Articles

Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes

Vinod K. Prasad, Adam Mendizabal, Suhag H. Parikh, Paul Szabolcs, Timothy A. Driscoll, Kristin Page, Sonali Lakshminarayanan, June Allison, Susan Wood, Deborah Semmel, Maria L. Escolar, Paul L. Martin, Shelly Carter, Joanne Kurtzberg

Blood (2008) 112 (7): 2979–2989.

https://doi.org/10.1182/blood-2008-03-140830

Published: 2008

Journal Articles

Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center.

Vinod K. Prasad, MD, MRCP, Adam Medizabal, MS, Suhag H. Parikh, MD, Paul Szabolcs, MD, Timothy A. Driscoll, MD, Kristin Page, MD, Sonali Lakshminarayanan, MBBS, June Allison, Susan Wood, Deborah Semmell, Maria L. Escolar, Paul L. Martin, MD, PhD, Shelly Carter, Joanne Kurtzberg, MD

Blood (2007) 110 (11): 336.

https://doi.org/10.1182/blood.V110.11.336.336

Published: 2007

Journal Articles

Use of Mesenchymal Stem Cells To Treat Pediatric Patients with Severe (Grade III–IV) Acute Graft Versus Host Disease Refractory to Steroid and Other Agents on a Compassionate Use Basis.

Vinod K. Prasad, MD, MRCP, Kenneth G. Lucas, MD, Gary I. Kleiner, MD, PhD, July-An M. Talano, MD, David Jacobsohn, MD, Paul Szabolcs, MD, Rod Monroy, PhD, Joanne Kurtzberg, MD

Blood (2007) 110 (11): 2971.

https://doi.org/10.1182/blood.V110.11.2971.2971

Published: 2007

Journal Articles

Melphalan Containing Cytoreduction Results in a Good Overall Survival (OS) in Pediatric Patients with Relapse or Refractory AML Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT).

Vinod K. Prasad, MD, MRCP, Juan Wu, MS, Paul L. Martin, MD, PhD, Timothy A. Driscoll, MD, Suhag H. Parikh, MD, Deborah Semmel, FNP, Jerelyn Moffet, PNP, Lauren Stafford, PNP, Ann Shonkwiler, PNP, Shelly Carter, Sc.D, Paul Szabolcs, MD, Joanne Kurtzberg, MD

Blood (2006) 108 (11): 3150.

https://doi.org/10.1182/blood.V108.11.3150.3150

Published: 2006

Journal Articles

Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.

Sonali Lakshminarayanan, MD, Paul Szabolcs, MD, Vinod K. Prasad, MD, MRCP, Suhag Parikh, MD, June Allison, RN, CPON, Susan J. Wood, MN, CPNP, Maria Escolar, MD, Joanne Kurtzberg, MD

Blood (2005) 106 (11): 2050.

https://doi.org/10.1182/blood.V106.11.2050.2050

Published: 2005

Journal Articles

DNA Typing for HLA-A and HLA-B Identifies Disparities Between Patients and Unrelated Donors Matched by HLA-A and HLA-B Serology and HLA-DRB1

Vinod K. Prasad, Nancy A. Kernan, Glenn Heller, Richard J. O’Reilly, Soo Young Yang

Blood (1999) 93 (1): 399–409.

https://doi.org/10.1182/blood.V93.1.399

Published: 1999

NARROW

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection

Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Transplantation Following Myeloablative Cytoreduction Results in Excellent Survival, Long-Term Engraftment, and Donor Chimerism in Children with Chronic Granulomatous Disease Across Donor and Graft Sources.

Differential Impact of Inhibitory and Activating Killer Ig-Like Receptors and HLA Ligand on Outcomes of Transplantation for Myeloid and Lymphoid Malignancies.

Single Donor 4/6 Matched Banked Unrelated Cord Blood Is An Effective Graft Source for Children Undergoing Myeloablative Transplantation for Malignant and Nonmalignant Disorders: Single Center Analysis of 318 Patients.

Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies

Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes

Analysis of the Cellular Components of the Graft and Clinical Characteristics of 159 Children with Lysosomal and Peroxisomal Disorders (LSD) Undergoing Unrelated Umbilical Cord Blood Transplantation at a Single Center.

Use of Mesenchymal Stem Cells To Treat Pediatric Patients with Severe (Grade III–IV) Acute Graft Versus Host Disease Refractory to Steroid and Other Agents on a Compassionate Use Basis.

Melphalan Containing Cytoreduction Results in a Good Overall Survival (OS) in Pediatric Patients with Relapse or Refractory AML Undergoing Unrelated Umbilical Cord Blood Transplantation (UCBT).

Transplant Outcomes and Stabilization of Neurological Function in Young Children with MPS III (Sanfilippo Syndrome) after Unrelated Donor Umbilical Cord Blood Transplantation.

DNA Typing for HLA-A and HLA-B Identifies Disparities Between Patients and Unrelated Donors Matched by HLA-A and HLA-B Serology and HLA-DRB1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only